Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;73(9):1765-1767.
doi: 10.1002/art.41742. Epub 2021 Jul 31.

Prophylaxis Against COVID-19 With Hydroxychloroquine and Chloroquine: Comment on the Article by Putman et al

Wei Tang  1 , Yevgeniya Gartshteyn  1 , Cathy Guo  1 , Tommy Chen  1 , Jon Giles  1 , Anca Askanase  1
Affiliations
Comment

Prophylaxis Against COVID-19 With Hydroxychloroquine and Chloroquine: Comment on the Article by Putman et al

Wei Tang et al. Arthritis Rheumatol. 2021 Sep.
No abstract available

PubMed Disclaimer

Comment in

  • Reply.
    Putman M, Sattui SE, Sparks JA, Liew JW, Grainger R, Duarte-García A. Putman M, et al. Arthritis Rheumatol. 2021 Sep;73(9):1767-1768. doi: 10.1002/art.41745. Epub 2021 Aug 3. Arthritis Rheumatol. 2021. PMID: 33779057 Free PMC article. No abstract available.

Comment on

  • Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.
    Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A; COVID-19 Global Rheumatology Alliance. Putman M, et al. Arthritis Rheumatol. 2021 Jan;73(1):36-47. doi: 10.1002/art.41469. Epub 2020 Nov 19. Arthritis Rheumatol. 2021. PMID: 32741139 Free PMC article.

References

    1. Putman M, Chock YP, Tam H, Kim AH, Sattui SE, Berenbaum F, et al. Antirheumatic disease therapies for the treatment of COVID‐19: a systematic review and meta‐analysis. Arthritis Rheumatol 2021;73:36–47. - PMC - PubMed
    1. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019‐nCoV) in vitro. Cell Res 2020;30:269–71. - PMC - PubMed
    1. Ladapo JA, McKinnon JE, McCullough PA, Risch HA. Randomized controlled trials of early ambulatory hydroxychloroquine in the prevention of COVID‐19 infection, hospitalization, and death: meta‐analysis [preprint]. medRxiv 2020. E‐pub ahead of print.
    1. Abella BS, Jolkovsky EL, Biney BT, Uspal JE, Hyman MC, Frank I, et al. Efficacy and safety of hydroxychloroquine vs placebo for pre‐exposure SARS‐CoV‐2 prophylaxis among health care workers: a randomized clinical trial. JAMA Intern Med 2021;181:195–202. - PMC - PubMed
    1. Rajasingham R, Bangdiwala AS, Nicol MR, Skipper CP, Pastick KA, Axelrod ML, et al. Hydroxychloroquine as pre‐exposure prophylaxis for COVID‐19 in healthcare workers: a randomized trial. Clin Infect Dis 2021;72:e835–43. - PMC - PubMed

LinkOut - more resources